Missing/wrong data?
Log in to edit
A high-content screening of anti-cancer compounds suggests the multiple tyrosine kinase inhibitor ponatinib for repurposing in neuroblastoma therapy.
scientific article
Author/s
author: Viktoryia Sidarovich, Sanja Aveic, Luigi Pasini, Michela Croce, Marianna Avitabile, Alessandro Quattrone, Gian Paolo Tonini, Luca Longo
Work details
Publication date
April 25, 2018
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.